Key terms
About ONVO
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ONVO news
Apr 15
8:08am ET
Organovo announces Phase 2 results for FXR314
Apr 12
5:18pm ET
Organovo files to sell common stock, warrants, no amount given
Feb 08
4:13am ET
Organovo Holdings Unveils Corporate Presentation Online
Jan 26
5:11pm ET
Organovo files $150M mixed securities shelf
Jan 25
8:09am ET
Organovo presents FXR314 3D human tissue model findings
No recent press releases are available for ONVO
ONVO Financials
Key terms
Ad Feedback
ONVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ONVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range